\
&
Contact us
Published on | 1 year ago
Programmes MSCA MSCAThe Marie Skłodowska-Curie Actions (MSCA) fund excellent research and innovation and equip researchers at all stages of their careers with new knowledge and skills through five different actions: Doctoral Networks (DN), Postdoctoral Fellowships (PF), Staff Exchanges (SE), COFUND, and MSCA and Citizens. Costs under these actions are reimbursed on the basis of lump sum and unit contributions, the latter covering costs for recruited researchers, seconded staff members as well as institutional costs. The current rates were established in 2020 in the Decision of 11 March 2021 authorising the use of lump sum and unit contributions for MSCA under the Horizon Europe Programme.
The above-mentioned Decision requires the Commission to closely monitor the lump sum and unit contributions to ensure that they respect sound financial management and co-financing principles, do not contribute to double financing and remain sufficiently competitive and attractive to excellent researchers and institutions. Thus, the objective of this study is to carry out a mid-term review of the MSCA lump sum and unit contributions, and to recommend updated eligible researcher and institutional unit contributions for each Marie Skłodowska-Curie action. (from the abstract of the study)
Based on the conducted analysis, the study proposes 10 recommendations for the MSCA funding system (p.86) among others:
Update: as of the 2024 MSCA calls changes to the CCC and allowances have been implemented, i.e. included in the Horizon Europe MSCA 2023-2025 work programme (17 April 2024).
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.